13.07.2015 Views

Medical Aspects of Chemical Warfare (2008) - The Black Vault

Medical Aspects of Chemical Warfare (2008) - The Black Vault

Medical Aspects of Chemical Warfare (2008) - The Black Vault

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Medical</strong> Diagnosticshalf-life rates (16.5 min for guinea pigs; 9 min formarmosets). 8 Inhalation experiments using nose-onlyexposure <strong>of</strong> guinea pigs to 0.8 × LCt 50(the vapor oraerosol exposure that is lethal to 50% <strong>of</strong> the exposedpopulation) agent demonstrate terminal half-lives <strong>of</strong>approximately 36 and 9 minutes for sarin and soman,respectively. 9 In contrast, similar studies with VX inhairless guinea pigs and marmosets indicate VX ismore persistent than the G agents. 10 <strong>The</strong>se studiesshow that VX can be found at acutely toxic levels for10 to 20 hours following intravenous administrationat a dose one or two times the LD 50, with terminalelimination rates <strong>of</strong> 98 minutes (1 times the LD 50inhairless guinea pigs), 165 minutes (2 times the LD 50),and 111 minutes in marmosets (at a dose equivalentto 1 LD 50in hairless guinea pigs). Percutaneous administration<strong>of</strong> the LD 50<strong>of</strong> VX to hairless guinea pigsdemonstrated relatively low blood levels (140 pg/mL), which reached a maximum after approximately6 hours. 10 Because the route <strong>of</strong> human exposure toVX would most likely occur percutaneously, the timeframe <strong>of</strong> 6 hours may be the more relevant assessment<strong>of</strong> its persistence in blood. This allows very limitedtime for sample collection and analysis. Others havedemonstrated that VX can be assayed from spikedrat plasma. 11 <strong>The</strong>se authors noted that 53% <strong>of</strong> the VXwas lost in spiked plasma specimens after 2 hours.<strong>The</strong> disappearance was attributed to the enzymeaction <strong>of</strong> the OP hydrolase splitting or to cleavage<strong>of</strong> the sulfur-phosphorus bond to form diisopropylaminoethanethiol (DAET) and ethyl methylphosphonicacid (EMPA). 11Assay <strong>of</strong> Hydrolysis CompoundsAnalytical MethodsAn alternative approach to direct assay <strong>of</strong> parentnerve agents is to measure metabolic or hydrolysisproducts in specimens. <strong>The</strong>se compounds are producedin vivo as a result <strong>of</strong> hydrolysis or detachmentfollowing spontaneous regeneration <strong>of</strong> the AChEenzyme. Studies <strong>of</strong> parent nerve agents with radioisotopicallylabeled phosphorus ( 32 P) or hydrogen ( 3 H) inanimals suggest that agents are rapidly metabolizedand hydrolyzed in the blood and appear in the urineas their respective alkyl MPAs. 12–15 This observationled to the development <strong>of</strong> assays for alkyl MPAs inbiological samples, 16 the applicability <strong>of</strong> which wassubsequently demonstrated in animals exposed tonerve agents. 17 <strong>The</strong> common products found areisopropyl methylphosphonic acid (IMPA), pinacolylmethylphosphonic acid, cyclohexyl methylphosphonicacid, and EMPA derived from sarin, soman, cyclosarin,and VX, respectively (Figure 22-2). Additionally forVX, hydrolysis <strong>of</strong> the sulfur-phosphorus bond occurs,yielding DAET and EMPA. <strong>The</strong> formation and assay<strong>of</strong> DAET has been reported in rat plasma spiked withVX. 11 Furthermore, the presence <strong>of</strong> diisopropyl aminoethylmethyl sulfide, presumably resulting from thein-vivo methylation <strong>of</strong> DAET, has been reported in humanexposures. 18 To date, numerous variations <strong>of</strong> thealkyl MPA assay for biological fluids, such as plasmaand urine, have been developed. <strong>The</strong>se include GCseparations with MS, 18–20 tandem MS (MS-MS), 18,19,21,22and flame photometric detection. 23,24 Other methodsinvolving LC with MS-MS 25 and indirect photometricdetection 26 have also been reported (Table 22-1).Application to Human Exposures<strong>The</strong> utility <strong>of</strong> some methodologies has been demonstratedin actual human exposure incidents. Mostinvolve assays <strong>of</strong> urine and plasma or serum. Tsuchihashiet al 18 demonstrated the presence <strong>of</strong> EMPA inthe serum <strong>of</strong> an individual assassinated with VX inOsaka, Japan, in 1994. As mentioned earlier, theseauthors also reported the presence <strong>of</strong> diisopropylaminoethyl methyl sulfide, which resulted from thein-vivo methylation <strong>of</strong> DAET subsequent to cleavage <strong>of</strong>the sulfur-phosphorus bond. Reported concentrationsin serum collected 1 hour after exposure were 143 ng/mL diisopropyl aminoethyl methyl sulfide and 1.25μg/mL for EMPA.<strong>The</strong> Aum Shinrikyo cult attacked citizens twice inJapan using sarin. <strong>The</strong> first was in an apartment complexin Matsumoto City, where approximately 12 liters<strong>of</strong> sarin were released using a heater and fan. Accordingto police reports, 600 inhabitants in the surroundingarea were harmed, including 7 who were killed.In the second attack, sarin was released into the Tokyosubway, resulting in more than 5,000 casualties and 10deaths. 27 Assay <strong>of</strong> hydrolysis products as a definitivemarker were used to verify that sarin was the agent employedin these events. Minami et al 23 and Nakajima etal 24 demonstrated the presence <strong>of</strong> IMPA or MPA in victims’urine following sarin exposure in the Tokyo andMatsumoto attacks, respectively. <strong>The</strong>se methods usedGC separations <strong>of</strong> the prepared urine matrix coupledwith flame photometric detection. In the Matsumotoincident, urinary concentrations <strong>of</strong> IMPA and MPA,as well as the total dose <strong>of</strong> the sarin exposure, werereported. 24 For one victim, MPA concentrations were0.14 and 0.02 ug/mL on the first and third days afterexposure, and 0.76, 0.08, and 0.01 ug/mL for IMPA,respectively, on the first, third, and seventh days afterexposure. 24 In this case, the individual was estimatedto have been exposed to 2.79 mg <strong>of</strong> sarin.695

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!